Real-World Evidence vs Clinical Trials: Post-Marketing Surveillance...

ha aggiunto una foto Health

2025-12-02 12:58:36 - Translate -

Real-World Evidence vs Clinical Trials: Post-Marketing Surveillance Reinforcing the Safety Advantage in the Apixaban Market

The Apixaban Market exhibits significant regional variations in adoption and penetration, largely driven by differential healthcare funding models, regulatory maturity, and awareness levels regarding modern anticoagulants. Developed regions, particularly North America and Western Europe, represent the primary revenue base due to high NVAF and VTE diagnosis rates, strong reimbursement policies,...

0 Commenti 0 condivisioni 226 Views